difference between glp 1 and tirzepatide Compound Vs GLP-1 Medications: Key Differences Semaglutide vs. Tirzepatide: Which GLP-1

The Truth Emerges On July 29, 2025, Novo issued a press release and held a conference call lowering its sales and profit outlook for 2025, citing "lowered growth expectations for the second half of 2025" for both Wegovy and Ozempic due to "the persistent use of compounded GLP-1s, slower-than-expected market expansion and competition." Management also noted that despite the expiry of the FDA grace period for mass compounding on May 22, 2025, company research showed that unsafe and unlawful mass compounding continued

Easy Mixing: Dissolves easily in liquids for convenient consumption

Pricing is competitive - lower than Henry Meds ($297) and Lemonaid ($348) while including far more services

LX2006 gene therapy - drug development pipeline

#LifeWave #YAge #SharetheLight | LifeWave Corporate